https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accounts-payable https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accounts-receivable https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accrual-carrying-value-payments https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accrued-liabilities-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/accumulated-depreciation https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/additional-paid-in-capital https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/advertising-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/amended-reports-10-q https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/amortization https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/assets-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/basic-shares https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-expenditures https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/cash-and-equivalents https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/cash-flow-breakdown https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/common-dividends-paid https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/common-stock-value https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/comprehensive-income https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/cost-of-revenue https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-liabilities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/debt-issued https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/depreciation https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/depreciation-and-amortization https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/diluted-shares https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/dilutive-shares https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/dividends-common-stock https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/effective-tax-rate https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/eps https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/eps-basic https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/gain-loss-on-investments https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/gross-profit https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-tax https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/income-taxes-paid https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/increase-decrease-in-prepaid-taxes https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/insider-transactions-other https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/interest-and-other-income https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/interest-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/interest-paid https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/inventory https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/inventory-finished-goods https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/inventory-raw-materials https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/inventory-work-in-process https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/inventory-write-down https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/land https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/land-subject-to-ground-leases https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/litigation-reserve https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/litigation-settlement-amount https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/long-term-debt https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-cash-from https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-cash-from-discontinued-operations https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-change-in-cash https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/net-income https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/number-of-defendants https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/number-of-reportable-segments https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/oci-net-of-tax https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/other-current-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/other-depreciation-and-amortization https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/other-income https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/other-noncurrent-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/preferred-shares-facts https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/prepaid-royalties https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/prepaid-taxes https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/proceeds-from-royalties-received https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/property-plant-equipment https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/public-float https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/purchase-obligation-due-in-fifth-year https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/real-estate-and-accumulated-depreciation-carrying-amount-of-land https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/research-and-development https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/research-and-development-arrangement-contract-to-perform-for-others-compensation-earned https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/retained-earnings https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/revenue https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/royalty-income-nonoperating https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-10-k https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-10-q https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-10ksb https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-10qsb https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-15-12g https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-25-nse https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-8-k https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-ars https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-ct-order https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-def-14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-defa14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-defm14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-prem14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sec-filings-prer14a https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/sga-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/shareholders-equity https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/shares-authorized https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/shares-issued https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-based-compensation https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tangible-asset-impairment-charges https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-benefit-from-stock-options-exercised https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/taxes-payable-current https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/total-assets https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/total-liabilities https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/treasury-shares-acquired https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/treasury-stock-shares https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/treasury-stock-value https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/hi-tech-pharmacal-co-inc/valuation-allowances-and-reserves-change